Selective determination, in plasma, of artemether and its major metabolite, dihydroartemisinin, by high-performance liquid chromatography with ultraviolet detection

C. G. Thomas, Steve Ward, G. Edwards

Research output: Contribution to journalArticlepeer-review

68 Citations (Scopus)

Abstract

A sensitive and selective reversed-phase high-performance liquid chromatographic method for the determination of artemether and its major metabolite dihydroartemisinin in plasma has been developed. It involves extraction of plasma with dichloromethane, solid-phase separation of the two analytes and acid decomposition prior to chromatography on a C18 Spherisorb column with a mobile phase of acetonitrile-water (50:50, v/v). Run time is 30 min. The assay satisfies all of the criteria required for use in clinical pharmacokinetic studies.
Original languageEnglish
Pages (from-to)131-136
Number of pages6
JournalJournal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences
Volume583
Issue number1
DOIs
Publication statusPublished - 27 Nov 1992

Fingerprint

Dive into the research topics of 'Selective determination, in plasma, of artemether and its major metabolite, dihydroartemisinin, by high-performance liquid chromatography with ultraviolet detection'. Together they form a unique fingerprint.

Cite this